Difference between revisions of "Part:BBa K3365000:Design"

(→‎Design Notes)
(→‎References)
 
(6 intermediate revisions by 2 users not shown)
Line 11: Line 11:
 
===Source===
 
===Source===
  
−
From the plasmid, pWJ66.
+
The sequence of the part is from the plasmid, pWJ66. The fragment is synthesized by the company.
  
 
===References===
 
===References===
 +
 +
[1] BIKARD D, JIANG W, SAMAI P, et al. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system[J]. Nucleic Acids Res, 2013,41(15): 7429-7437.
 +
 +
[2] Yao R, Liu D, Jia X, Zheng Y, Liu W, Xiao Y. CRISPR-Cas9/Cas12a biotechnology and application in bacteria. Synth Syst Biotechnol. 2018 Oct 3;3(3):135-149.

Latest revision as of 18:17, 27 October 2020


dCas9-ω


Assembly Compatibility:
  • 10
    INCOMPATIBLE WITH RFC[10]
    Illegal EcoRI site found at 1340
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal EcoRI site found at 1340
    Illegal NheI site found at 1099
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal EcoRI site found at 1340
    Illegal BamHI site found at 3378
    Illegal BamHI site found at 4212
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal EcoRI site found at 1340
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal EcoRI site found at 1340
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

None.

Source

The sequence of the part is from the plasmid, pWJ66. The fragment is synthesized by the company.

References

[1] BIKARD D, JIANG W, SAMAI P, et al. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system[J]. Nucleic Acids Res, 2013,41(15): 7429-7437.

[2] Yao R, Liu D, Jia X, Zheng Y, Liu W, Xiao Y. CRISPR-Cas9/Cas12a biotechnology and application in bacteria. Synth Syst Biotechnol. 2018 Oct 3;3(3):135-149.